
  
    
      
        Introduction_NNP
        Stroke_NNP is_VBZ the_DT third_JJ leading_VBG cause_NN of_IN death_NN in_IN the_DT United_NNP
        States_NNPS ,_, after_IN heart_NN disease_NN and_CC cancer_NN ,_, and_CC the_DT leading_VBG
        cause_NN of_IN adult_NN disability_NN ._. [_NN 1_CD ]_NN In_IN 1994_CD ,_, Matchar_NNP and_CC Duncan_NNP
        [_NN 2_CD ]_NN claimed_VBD that_IN each_DT year_NN there_EX are_VBP ≈_NN 550_CD ,_, 000_CD strokes_NNS in_IN
        the_DT US_NNP ,_, causing_VBG 150_CD ,_, 000_CD deaths_NNS and_CC leaving_VBG 300_CD ,_, 000_CD
        survivors_NNS disabled_JJ ._. The_DT 
        Heart_NNP and_CC Stroke_NNP Statistical_NNP Update_NNP [_NN
        3_CD ,_, 4_CD ]_NN of_IN the_DT American_NNP Heart_NNP Association_NNP (_( 1995_CD ,_, 1997_CD )_) states_NNS
        that_WDT ≈_NN 500_CD ,_, 000_CD Americans_NNPS suffer_VBP a_DT first-ever_JJ or_CC recurrent_JJ
        stroke_NN each_DT year_NN ._. All_DT three_CD reports_NNS were_VBD based_VBN on_IN the_DT
        predominately_RB white_JJ cohort_NN study_NN of_IN Framingham_NNP ,_,
        Massachusetts_NNP ._. In_IN 1998_CD ,_, Broderick_NNP et_CC al_NN [_NN 5_CD ]_NN hypothesized_VBN
        that_IN the_DT figure_NN of_IN approximately_RB half_PDT a_DT million_CD strokes_NNS
        substantially_RB underestimates_NNS the_DT actual_JJ annual_JJ stroke_NN
        burden_NN for_IN the_DT United_NNP States_NNPS ._. They_PRP claimed_VBD that_IN there_EX were_VBD
        at_IN least_JJS 731_CD ,_, 000_CD first-ever_JJ or_CC recurrent_JJ strokes_NNS during_IN
        1996_CD ._. [_NN 5_CD ]_NN This_DT estimate_NN was_VBD derived_VBN by_IN extrapolating_VBG from_IN
        first-ever_JJ strokes_NNS among_IN whites_NNS in_IN the_DT Rochester_NNP ,_, Minnesota_NNP
        Stroke_NNP Study_NNP ._. The_DT 1999_CD 
        Heart_NNP and_CC Stroke_NNP Statistical_NNP Update_NNP [_NN
        6_CD ]_NN of_IN the_DT American_NNP Heart_NNP Association_NNP adjusted_VBD their_PRP$
        estimate_NN to_TO ≈_NN 600_CD ,_, 000_CD first-ever_JJ or_CC recurrent_JJ strokes_NNS each_DT
        year_NN in_IN the_DT US_NNP ._.
        Population-based_NNP stroke_NN incidence_NN studies_NNS such_JJ as_IN those_DT
        from_IN Framingham_NNP ,_, Massachusetts_NNP and_CC Rochester_NNP ,_, Minnesota_NNP
        have_VBP substantially_RB increased_VBN the_DT knowledge_NN about_IN stroke_NN
        trends_NNS ,_, subtypes_NNS ,_, risk_NN factors_NNS and_CC incidence_NN rates_NNS in_IN both_DT
        men_NNS and_CC women_NNS ._. However_RB ,_, these_DT studies_NNS were_VBD conducted_VBN among_IN
        predominately_RB white_JJ populations_NNS ._. Recently_RB ,_, epidemiological_JJ
        studies_NNS have_VBP been_VBN focusing_VBG on_IN differences_NNS in_IN stroke_NN
        incidence_NN between_IN racial_JJ /_NN ethnic_JJ groups_NNS ._. Of_IN particular_JJ
        interest_NN are_VBP rates_NNS for_IN blacks_NNS ;_: however_RB ,_, there_EX is_VBZ little_JJ
        data_NNS regarding_VBG stroke_NN risk_NN in_IN Hispanics_NNPS or_CC Asians_NNPS ._. Recent_JJ
        data_NNS from_IN Northern_NNP Manhattan_NNP suggest_VBP that_IN blacks_NNS are_VBP not_RB
        alone_RB in_IN the_DT higher_JJR risk_NN category_NN and_CC that_IN Hispanics_NNPS also_RB
        appear_VB to_TO be_VB at_IN greater_JJR risk_NN than_IN whites_NNS ._. [_NN 7_CD ]_NN
        In_IN order_NN to_TO get_VB a_DT more_RBR accurate_JJ estimate_NN of_IN occurrences_NNS
        of_IN stroke_NN in_IN the_DT US_NNP ,_, Williams_NNP et_CC al_NN [_NN 8_CD ]_NN estimated_VBD the_DT 1995_CD
        incidence_NN ,_, occurrence_NN and_CC characteristics_NNS of_IN total_JJ stroke_NN
        based_VBN on_IN a_DT large_JJ administrative_JJ claims_NNS database_NN
        representative_NN of_IN all_DT 1995_CD US_NNP inpatient_NN discharges_NNS ._. They_PRP
        conservatively_RB claimed_VBD that_IN there_EX were_VBD ≈_NN 750_CD ,_, 000_CD first-ever_JJ
        or_CC recurrent_JJ strokes_NNS during_IN 1995_CD ._.
        The_DT primary_JJ goal_NN of_IN this_DT paper_NN was_VBD to_TO replicate_VB the_DT
        recent_JJ estimates_NNS of_IN Broderick_NNP et_CC al_NN [_NN 5_CD ]_NN and_CC Williams_NNP et_CC
        al_NN ,_, [_NN 8_CD ]_NN and_CC to_TO examine_VB the_DT trend_NN from_IN 1995_CD to_TO 1996_CD ._. This_DT
        was_VBD accomplished_VBN by_IN use_NN of_IN a_DT large_JJ administrative_JJ claims_NNS
        database_NN representing_VBG a_DT 20_CD %_NN representative_NN sample_NN of_IN all_DT
        1996_CD US_NNP inpatient_NN discharges_NNS ._. The_DT administrative_JJ database_NN
        was_VBD supplemented_JJ by_IN appropriate_JJ adjustments_NNS for_IN the_DT 
        International_NNP Classification_NNP of_IN Diseases_NNP ,_,
        9_CD th_NN Revision_NNP ,_, Clinical_NNP Modification_NNP (_( ICD-_NNP 9_CD -_: CM_NNP )_) codes_NNS
        430_CD -_: 438_CD derived_VBN by_IN Williams_NNP et_CC al_NN [_NN 8_CD ]_NN to_TO correct_VB for_IN some_DT
        of_IN the_DT inaccuracies_NNS of_IN the_DT diagnostic_JJ codes_NNS ._.
      
      
        Subjects_NNP and_CC Methods_NNP
        
          Nationwide_NNP Inpatient_NNP Sample_NNP Database_NNP
          This_DT study_NN employed_VBN the_DT Nationwide_NNP Inpatient_NNP Sample_NNP
          (_( NIS_NNP )_) of_IN the_DT Healthcare_NNP Cost_NN and_CC Utilization_NN Project_NNP
          (_( HCUP_NNP )_) ,_, release_NN 5_CD ,_, which_WDT is_VBZ a_DT large_JJ administrative_JJ claims_NNS
          database_NN that_WDT is_VBZ a_DT 20_CD %_NN representative_NN sample_NN of_IN all_DT 1996_CD
          US_NNP inpatient_NN discharges_NNS ._. The_DT fifth_JJ release_NN of_IN the_DT NIS_NNP
          contains_VBZ 6_CD ._. 5_CD million_CD discharges_NNS from_IN a_DT sample_NN of_IN 906_CD
          hospitals_NNS covering_VBG 19_CD geographically_RB dispersed_VBD states_NNS ._.
          Compared_VBN to_TO the_DT fourth_JJ release_NN ,_, [_NN 8_CD ]_NN the_DT fifth_JJ release_NN
          uses_VBZ 32_CD fewer_JJR hospitals_NNS and_CC contains_VBZ 0_CD ._. 2_CD million_CD fewer_JJR
          discharges_NNS ._. Similar_JJ to_TO those_DT of_IN the_DT fourth_JJ release_NN ,_, these_DT
          data_NNS also_RB represent_VBP a_DT 20_CD %_NN stratified_JJ sample_NN of_IN all_DT U_NNP ._. S_NNP ._.
          inpatient_NN discharges_NNS ._. Stratification_NNP variables_NNS included_VBD
          region_NN ,_, control_NN ,_, location_NN ,_, teaching_NN status_NN and_CC bedsize_NN ._.
          The_DT software_NN program_NN SUDAAN_NNP [_NN 9_CD ]_NN was_VBD used_VBN to_TO convert_VB raw_JJ
          counts_VBZ generated_VBN from_IN the_DT NIS_NNP database_NN into_IN weighted_JJ
          counts_NNS that_WDT represent_VBP national_JJ estimates_NNS ._.
          Inpatient_NNP records_NNS included_VBD clinical_JJ and_CC resource_NN use_NN
          information_NN typically_RB available_JJ from_IN discharge_NN abstracts_NNS ._.
          The_DT NIS_NNP database_NN includes_VBZ most_RBS commonly_RB used_VBN data_NNS
          elements_NNS :_: patient_NN demographics_NNS ,_, admission_NN source_NN ,_,
          principal_JJ and_CC secondary_JJ diagnoses_NNS and_CC procedures_NNS ,_,
          expected_VBD primary_JJ source_NN of_IN payment_NN ,_, discharge_NN status_NN ,_,
          hospital_NN and_CC discharge_NN weights_NNS ,_, length_NN of_IN stay_NN and_CC total_JJ
          charges_NNS ._.
        
        
          Data_NNP Analysis_NNP
          We_PRP only_RB used_VBD the_DT first_JJ code_NN reported_VBD to_TO avoid_VB double_JJ
          counting_NN those_DT patients_NNS with_IN more_JJR than_IN one_CD reported_VBD
          ICD-_NNP 9_CD -_: CM_NNP code_NN 430_CD to_TO 438_CD at_IN discharge_NN ._. To_TO obtain_VB the_DT
          estimated_VBN number_NN of_IN stroke_NN cases_NNS by_IN ICD-_NNP 9_CD -_: CM_NNP code_NN ,_, we_PRP
          multiplied_VBN the_DT number_NN of_IN patients_NNS with_IN each_DT ICD-_NNP 9_CD -_: CM_NNP code_NN
          by_IN its_PRP$ estimated_VBN positive_JJ predictive_JJ value_NN (_( PPV_NNP )_) for_IN
          stroke_NN ._. [_NN 8_CD ]_NN The_DT total_JJ number_NN of_IN hospital_NN strokes_NNS was_VBD
          calculated_VBN by_IN summing_VBG across_IN codes_NNS ._. A_DT 95_CD %_NN confidence_NN
          interval_NN was_VBD computed_JJ by_IN utilizing_VBG Monte_NNP Carlo_NNP simulation_NN
          techniques_NNS [_NN 10_CD ]_NN (_( i_NNP ._. e_SYM ._. ,_, the_DT PPV_NNP distribution_NN for_IN each_DT
          code_NN was_VBD simulated_JJ by_IN using_VBG 10_CD ,_, 000_CD iterations_NNS of_IN a_DT
          binomial_NN distribution_NN whose_WP$ parameters_NNS were_VBD obtained_VBN by_IN
          pooling_VBG data_NNS from_IN four_CD published_VBN ICD-_NNP 9_CD stroke_NN validation_NN
          studies_NNS [_NN 5_CD ,_, 11_CD ,_, 12_CD ,_, 13_CD ]_NN )_) ._.
          Technically_RB ,_, an_DT incidence_NN rate_NN should_MD include_VB only_RB the_DT
          first_JJ episode_NN of_IN the_DT disease_NN being_VBG studied_VBN ._. However_RB ,_,
          because_IN this_DT database_NN does_VBZ not_RB distinguish_VB between_IN
          first-ever_JJ and_CC recurrent_JJ strokes_NNS ,_, total_JJ stroke_NN
          (_( first-ever_JJ and_CC recurrent_JJ )_) rates_NNS and_CC occurrences_NNS were_VBD
          reported_VBN ._. Stroke_NNP (_( first-ever_JJ )_) incidence_NN rates_NNS were_VBD
          estimated_VBN by_IN reducing_VBG the_DT total_JJ stroke_NN rates_NNS by_IN the_DT
          expected_VBN number_NN of_IN recurrent_JJ strokes_NNS ._. The_DT limited_JJ data_NN
          from_IN population-based_JJ cohorts_NNS suggest_VBP that_IN 25_CD %_NN to_TO 35_CD %_NN of_IN
          strokes_NNS are_VBP recurrent_JJ ._. [_NN 5_CD ,_, 14_CD ,_, 15_CD ]_NN Age-_NNP and_CC
          sex-standardized_JJ and_CC stratified_JJ incidence_NN rates_NNS of_IN total_JJ
          stroke_NN were_VBD also_RB estimated_VBN ._. These_DT were_VBD estimated_VBN by_IN using_VBG
          the_DT 1996_CD US_NNP census_NN population_NN figures_NNS ._. [_NN 16_CD ]_NN
        
        
          Nonhospital_NNP stroke_NN
          Even_RB though_IN ICD-_NNP 9_CD -_: CM_NNP principal_JJ and_CC secondary_JJ diagnosis_NN
          codes_NNS 430_CD to_TO 438_CD provide_VB virtually_RB complete_JJ ascertainment_NN
          of_IN hospital_NN strokes_NNS ,_, not_RB all_DT stroke_NN patients_NNS are_VBP
          hospitalized_VBN ._. Two_CD population-based_JJ stroke_NN incidence_NN
          studies_NNS ,_, [_NN 7_CD ,_, 17_CD ]_NN reported_VBD that_IN the_DT proportion_NN of_IN
          patients_NNS with_IN stroke_NN without_IN hospitalization_NN (_( nonhospital_NN
          strokes_NNS )_) was_VBD 5_CD %_NN and_CC 15_CD %_NN ,_, respectively_RB ._.
          Therefore_RB ,_, to_TO estimate_VB the_DT total_JJ number_NN of_IN strokes_NNS
          (_( hospital_NN and_CC nonhospital_NN )_) ,_, an_DT appropriate_JJ adjustment_NN was_VBD
          made_VBN in_IN the_DT analysis_NN ._. This_DT adjustment_NN conservatively_RB
          assumed_VBD that_IN 10_CD %_NN of_IN strokes_NNS were_VBD nonhospital_NN strokes_NNS ._.
          This_DT was_VBD a_DT simple_JJ mean_NN of_IN the_DT proportions_NNS published_VBN in_IN
          two_CD stroke_NN studies_NNS (_( 5_CD %_NN and_CC 15_CD %_NN )_) ._. Several_JJ international_JJ
          studies_NNS of_IN westernized_JJ countries_NNS have_VBP reported_VBN
          proportions_NNS ranging_VBG from_IN 10_CD to_TO 30_CD %_NN ._. [_NN 18_CD ]_NN The_DT two_CD
          published_VBN US_NNP proportions_NNS (_( 5_CD %_NN and_CC 15_CD %_NN )_) were_VBD also_RB used_VBN in_IN a_DT
          sensitivity_NN analysis_NN ._.
        
      
      
        Results_NNS
        The_DT 1996_CD results_NNS were_VBD compared_VBN to_TO those_DT of_IN 1995_CD [_NN 8_CD ]_NN (_( in_IN
        parentheses_NNS )_) ._. The_DT NIS_NNP database_NN contained_VBD 384_CD ,_, 968_CD (_( 377_CD ,_, 544_CD )_)
        patient_NN discharges_NNS with_IN a_DT principal_JJ or_CC secondary_JJ (_( first_JJ
        code_NN reported_VBD )_) diagnosis_NN of_IN cerebrovascular_NN disease_NN ._. This_DT
        was_VBD extrapolated_VBN to_TO 2_CD ,_, 082_CD ,_, 005_CD (_( 1_CD ,_, 977_CD ,_, 794_CD )_) patient_NN
        discharges_NNS in_IN the_DT United_NNP States_NNPS ._. Table_NNP 1_CD uses_VBZ the_DT ICD-_NNP 9_CD
        code-specific_JJ pooled_VBN PPVs_NNP [_NN 8_CD ]_NN to_TO adjust_VB for_IN false_JJ
        positives_NNS and_CC reports_NNS that_IN there_EX were_VBD 712_CD ,_, 000_CD (_( 682_CD ,_, 000_CD )_)
        hospital_NN strokes_NNS in_IN the_DT United_NNP States_NNPS ,_, with_IN a_DT 95_CD %_NN
        confidence_NN interval_NN of_IN 688_CD ,_, 000_CD (_( 660_CD ,_, 000_CD )_) to_TO 737_CD ,_, 000_CD
        (_( 704_CD ,_, 000_CD )_) ._. We_PRP believe_VBP that_IN at_IN least_JJS 71_CD ,_, 000_CD (_( 68_CD ,_, 000_CD )_)
        additional_JJ strokes_NNS were_VBD nonhospital_NN strokes_NNS ,_, 10_CD %_NN of_IN the_DT
        total_JJ occurrences_NNS of_IN stroke_NN ._. We_PRP thus_RB estimate_VBP that_IN there_EX
        were_VBD over_IN 783_CD ,_, 000_CD (_( 750_CD ,_, 000_CD )_) incident_NN and_CC recurrent_JJ strokes_NNS
        in_IN the_DT United_NNP States_NNPS in_IN 1996_CD (_( 1995_CD )_) ._. The_DT sensitivity_NN
        analysis_NN on_IN the_DT nonhospital_NN stroke_NN rate_NN produced_VBD a_DT range_NN
        from_IN 748_CD ,_, 000_CD (_( 716_CD ,_, 000_CD )_) to_TO 819_CD ,_, 000_CD (_( 784_CD ,_, 000_CD )_) ._.
        Of_IN the_DT estimated_VBN 712_CD ,_, 000_CD (_( 682_CD ,_, 000_CD )_) hospital_NN strokes_NNS ,_,
        23_CD ,_, 700_CD (_( 23_CD ,_, 400_CD )_) or_CC 3_CD ._. 3_CD %_NN (_( 3_CD ._. 4_LS %_NN )_) were_VBD subarachnoid_NN
        hemorrhages_NNS ,_, 74_CD ,_, 100_CD (_( 71_CD ,_, 600_CD )_) or_CC 10_CD ._. 4_LS %_NN (_( 10_CD ._. 5_LS %_NN )_) were_VBD
        intracerebral_NN hemorrhages_NNS ,_, and_CC the_DT remaining_VBG 615_CD ,_, 000_CD
        (_( 587_CD ,_, 000_CD )_) or_CC 86_CD ._. 4_LS %_NN (_( 86_CD ._. 1_LS %_NN )_) were_VBD ischemic_JJ strokes_NNS ._.
        The_DT overall_JJ incidence_NN rate_NN for_IN total_JJ stroke_NN (_( first-ever_JJ
        and_CC recurrent_JJ )_) was_VBD 269_CD (_( 259_CD )_) per_IN 100_CD ,_, 000_CD population_NN (_( age_NN
        and_CC sex-adjusted_JJ to_TO the_DT 1996_CD (_( 1995_CD )_) U_NNP ._. S_NNP ._. population_NN )_) ._. The_DT
        average_JJ annual_JJ age_NN and_CC sex-adjusted_JJ incidence_NN rate_NN for_IN
        first-ever_JJ stroke_NN was_VBD estimated_VBN to_TO be_VB 208_CD (_( 200_CD )_) per_IN
        100_CD ,_, 000_CD ._. Total_JJ stroke_NN incidence_NN rates_NNS increased_VBN
        exponentially_RB with_IN age_NN for_IN both_DT men_NNS and_CC women_NNS ._. In_IN addition_NN ,_,
        men_NNS had_VBD higher_JJR age-specific_JJ total_JJ stroke_NN incidence_NN rates_NNS
        than_IN did_VBD women_NNS ,_, as_IN illustrated_VBN in_IN Figure_NN 1_CD ._.
        Table_NNP 2_CD reports_NNS demographic_JJ and_CC clinical_JJ characteristics_NNS
        of_IN the_DT stroke_NN patients_NNS by_IN ICD-_NNP 9_CD -_: CM_NNP code_NN ._. The_DT mean_JJ age_NN of_IN
        all_DT patients_NNS with_IN stroke_NN was_VBD 72_CD ._. 1_LS (_( 72_CD ._. 1_LS )_) years_NNS ,_, 45_CD %_NN (_( 45_CD %_NN )_)
        were_VBD male_JJ ,_, 80_CD %_NN (_( 80_CD %_NN )_) were_VBD white_JJ ,_, and_CC 11_CD %_NN (_( 12_CD %_NN )_) of_IN the_DT
        patients_NNS died_VBD during_IN the_DT hospitalization_NN ._. A_DT
        disproportionately_RB low_JJ percentage_NN of_IN patients_NNS with_IN
        subarachnoid_NN hemorrhage_NN were_VBD male_JJ (_( 37_CD %_NN [_NN 37_CD %_NN ]_NN versus_CC 45_CD %_NN
        [_NN 45_CD %_NN ]_NN )_) ,_, and_CC as_IN expected_VBN ,_, the_DT patients_NNS with_IN subarachnoid_NN
        hemorrhage_NN were_VBD much_RB younger_JJR than_IN the_DT average_JJ stroke_NN
        patient_NN (_( 56_CD ._. 4_LS [_NN 56_CD ._. 6_CD ]_NN versus_CC 72_CD ._. 1_LS [_NN 72_CD ._. 1_LS ]_NN years_NNS )_) ._. The_DT
        inpatient_NN mortality_NN rates_NNS for_IN subarachnoid_NN and_CC
        intracerebral_NN hemorrhages_NNS were_VBD significantly_RB higher_JJR than_IN
        for_IN the_DT overall_JJ stroke_NN population_NN ,_, at_IN 27_CD %_NN (_( 26_CD %_NN )_) and_CC 28_CD %_NN
        (_( 29_CD %_NN )_) ,_, respectively_RB ._. A_DT surprisingly_RB high_JJ percentage_NN of_IN
        ICD-_NNP 9_CD -_: CM_NNP code_NN 432_CD patients_NNS were_VBD male_JJ (_( 60_CD %_NN [_NN 61_CD %_NN ]_NN versus_CC 40_CD %_NN
        [_NN 39_CD %_NN ]_NN )_) ,_, and_CC most_JJS code_NN 433_CD patients_NNS were_VBD white_JJ (_( 91_CD ._. 6_CD %_NN
        [_NN 92_CD ._. 5_LS %_NN ]_NN )_) ._.
        Table_NNP 2_CD also_RB presents_VBZ data_NNS on_IN resource_NN utilization_NN ._. For_IN
        the_DT index_NN hospitalization_NN ,_, the_DT stroke_NN patient_NN population_NN
        had_VBD a_DT mean_JJ length_NN of_IN stay_NN of_IN 9_CD ._. 0_CD (_( 9_CD ._. 8_CD )_) days_NNS (_( median_JJ 5_CD [_NN 5_CD ]_NN
        days_NNS )_) and_CC a_DT mean_JJ total_JJ charge_NN of_IN $_$ 18_CD ,_, 022_CD (_( 17_CD ,_, 711_CD )_) (_( median_JJ
        $_$ 8_CD ,_, 845_CD [_NN $_$ 8_CD ,_, 735_CD ]_NN )_) ._. Patients_NNS with_IN subarachnoid_NN and_CC
        intracerebral_NN hemorrhages_NNS had_VBD much_JJ longer_JJR length_NN of_IN stays_NNS ,_,
        averaging_VBG 13_CD ._. 9_CD (_( 14_CD ._. 0_CD )_) and_CC 10_CD ._. 3_LS (_( 10_CD ._. 5_LS )_) days_NNS ,_, respectively_RB ._.
        Their_PRP$ mean_NN total_JJ charges_NNS were_VBD also_RB higher_JJR ,_, at_IN $_$ 51_CD ,_, 193_CD
        (_( $_$ 46_CD ,_, 711_CD )_) and_CC $_$ 24_CD ,_, 409_CD (_( $_$ 23_CD ,_, 097_CD )_) ,_, respectively_RB ._. The_DT majority_NN
        of_IN stroke_NN patients_NNS had_VBD a_DT routine_JJ discharge_NN or_CC were_VBD
        discharged_VBN to_TO a_DT skilled_JJ nursing_NN facility_NN with_IN rates_NNS of_IN 39_CD %_NN
        (_( 39_CD %_NN )_) and_CC 18_CD %_NN (_( 17_CD %_NN )_) ,_, respectively_RB ._.
      
      
        Discussion_NNP
        Williams_NNP et_CC al_NN [_NN 8_CD ]_NN estimated_VBN that_IN there_EX were_VBD 750_CD ,_, 000_CD
        first-ever_JJ or_CC recurrent_JJ strokes_NNS in_IN 1995_CD ._. We_PRP conservatively_RB
        estimate_VBP that_IN there_EX were_VBD 783_CD ,_, 000_CD first-ever_JJ or_CC recurrent_JJ
        strokes_NNS in_IN 1996_CD ._. The_DT 33_CD ,_, 000_CD (_( 4_CD ._. 4_LS %_NN )_) increase_NN in_IN first-ever_JJ
        or_CC recurrent_JJ strokes_NNS may_MD be_VB due_JJ to_TO chance_NN ,_, but_CC it_PRP is_VBZ
        probably_RB due_JJ to_TO the_DT population_NN gain_NN (_( 262_CD ,_, 803_CD ,_, 000_CD in_IN 1995_CD
        versus_CC 265_CD ,_, 229_CD ,_, 000_CD in_IN 1996_CD ,_, a_DT 0_CD ._. 9_CD %_NN increase_NN )_) ,_, and_CC the_DT
        increase_NN in_IN aging_VBG (_( ≥_NN 65_CD years_NNS old_JJ )_) population_NN from_IN 1995_CD to_TO
        1996_CD (_( 33_CD ,_, 619_CD ,_, 000_CD in_IN 1995_CD versus_CC 33_CD ,_, 957_CD ,_, 000_CD in_IN 1996_CD ,_, a_DT 1_CD ._. 0_CD %_NN
        increase_NN )_) ._. [_NN 16_CD ]_NN The_DT aging_VBG population_NN effect_NN is_VBZ more_RBR
        pronounced_JJ in_IN the_DT group_NN aged_VBN 75_CD +_NN years_NNS who_WP are_VBP at_IN greater_JJR
        risk_NN of_IN stroke_NN (_( 14_CD ,_, 863_CD ,_, 000_CD in_IN 1995_CD versus_CC 15_CD ,_, 266_CD ,_, 000_CD in_IN
        1996_CD ,_, a_DT 2_CD ._. 7_CD %_NN increase_NN )_) ._. [_NN 16_CD ]_NN We_PRP also_RB estimate_VBP that_IN American_JJ
        hospitals_NNS charged_VBD $_$ 12_CD ._. 4_LS billion_CD for_IN stroke_NN treatment_NN and_CC
        management_NN during_IN 1996_CD ,_, which_WDT translates_NNS to_TO a_DT society_NN cost_NN
        of_IN approximately_RB $_$ 7_CD billion_CD ._.
        It_PRP is_VBZ worthwhile_JJ to_TO notice_VB the_DT remarkable_JJ consistency_NN in_IN
        stroke_NN patient_NN characteristics_NNS between_IN 1995_CD and_CC 1996_CD ,_, as_IN
        shown_VBN in_IN Table_NNP 2_CD ._. The_DT length_NN of_IN stay_NN ,_, however_RB ,_, was_VBD shorter_JJR
        in_IN 1996_CD than_IN in_IN 1995_CD for_IN stroke_NN patients_NNS ,_, although_IN the_DT
        total_JJ charge_NN was_VBD higher_JJR in_IN 1996_CD than_IN in_IN 1995_CD ._. It_PRP may_MD be_VB due_JJ
        to_TO a_DT combination_NN of_IN inflation_NN and_CC inpatient_NN healthcare_NN
        practice_NN changes_NNS or_CC healthcare_NN reimbursement_NN regulation_NN
        changes_NNS ._.
        The_DT present_JJ study_NN may_MD be_VB associated_VBN with_IN several_JJ
        limitations_NNS ._. First_LS ,_, the_DT validity_NN of_IN conclusions_NNS drawn_VBN from_IN
        analyses_NNS of_IN large_JJ administrative_JJ databases_NNS depends_VBZ on_IN the_DT
        accuracy_NN of_IN case-defining_JJ diagnostic_JJ codes_NNS ._. Therefore_RB ,_, the_DT
        validity_NN of_IN the_DT present_JJ study_NN is_VBZ highly_RB dependent_JJ on_IN the_DT
        accuracy_NN of_IN the_DT positive_JJ predictive_JJ values_NNS of_IN the_DT ICD-_NNP 9_CD -_: CM_NNP
        codes_NNS ,_, which_WDT has_VBZ been_VBN addressed_VBN ._. [_NN 8_CD ]_NN
        The_DT impact_NN of_IN the_DT uncertainty_NN in_IN the_DT PPV_NNP pooled_VBN
        estimates_NNS was_VBD examined_VBN by_IN constructing_VBG a_DT 95_CD %_NN confidence_NN
        interval_NN around_IN the_DT number_NN of_IN hospital_NN strokes_NNS ._. The_DT bounds_NNS
        of_IN this_DT confidence_NN interval_NN were_VBD tight_JJ (_( 688_CD ,_, 000_CD ,_, 737_CD ,_, 000_CD )_) ,_,
        indicating_VBG that_IN the_DT point_NN estimate_NN had_VBD reasonable_JJ
        precision_NN ._.
        Another_DT limitation_NN of_IN the_DT present_JJ study_NN is_VBZ the_DT lack_NN of_IN
        documented_VBN information_NN on_IN the_DT rate_NN of_IN nonhospital_NN stroke_NN ._.
        Additional_JJ data_NNS are_VBP needed_VBN to_TO produce_VB a_DT more_RBR reliable_JJ
        estimate_NN of_IN the_DT proportion_NN of_IN strokes_NNS without_IN
        hospitalization_NN ._. By_IN intentionally_RB choosing_VBG a_DT low_JJ
        percentage_NN ,_, we_PRP were_VBD confident_JJ that_IN our_PRP$ estimate_NN of_IN the_DT
        total_JJ annual_JJ stroke_NN burden_NN was_VBD not_RB inflated_VBN ._. We_PRP used_VBD
        sensitivity_NN analyses_NNS to_TO illustrate_VB the_DT potential_JJ impact_NN of_IN
        a_DT different_JJ true_JJ percentage_NN ._. In_IN addition_NN ,_, race-specific_JJ
        information_NN was_VBD not_RB available_JJ ,_, which_WDT limited_JJ our_PRP$ ability_NN to_TO
        adjust_VB for_IN race_NN ._.
        The_DT methodology_NN used_VBN in_IN the_DT present_JJ study_NN was_VBD the_DT same_JJ
        as_IN the_DT one_CD used_VBN in_IN Williams_NNP et_CC al_NN ,_, [_NN 8_CD ]_NN but_CC different_JJ from_IN
        other_JJ studies_NNS published_VBN on_IN the_DT incidence_NN ,_, occurrence_NN and_CC
        characteristics_NNS of_IN stroke_NN ._. All_DT those_DT studies_NNS used_VBD
        state-of-the-art_JJ stroke_NN registries_NNS based_VBN in_IN relatively_RB
        small_JJ geographical_JJ areas_NNS (_( Framingham_NNP ,_, Massachusetts_NNP ;_:
        Rochester_NNP ,_, Minnesota_NNP ;_: Rochester_NNP ,_, New_NNP York_NNP ;_: Northern_NNP
        Manhattan_NNP ,_, New_NNP York_NNP ;_: Greater_NNP Cincinnati_NNP /_NN Northern_NNP Kentucky_NNP )_) ._.
        Our_PRP$ approach_NN might_MD have_VB slightly_RB reduced_VBN internal_JJ validity_NN ,_,
        but_CC it_PRP should_MD have_VB far_RB greater_JJR external_JJ validity_NN ,_, although_IN
        this_DT might_MD be_VB somewhat_RB compromised_VBN by_IN the_DT reduced_VBN internal_JJ
        validity_NN ._.
        In_IN summary_NN ,_, this_DT study_NN supports_VBZ the_DT findings_NNS of_IN
        Broderick_NNP et_CC al_NN [_NN 5_CD ]_NN and_CC Williams_NNP et_CC al_NN [_NN 8_CD ]_NN by_IN
        conservatively_RB estimating_VBG that_IN there_EX are_VBP approximately_RB
        three-quarters_NNS of_IN a_DT million_CD strokes_NNS each_DT year_NN ._. In_IN addition_NN ,_,
        we_PRP observed_VBD that_IN there_EX is_VBZ a_DT slight_JJ increase_NN ,_, although_IN not_RB
        statistically_RB significant_JJ ,_, in_IN occurrences_NNS of_IN stroke_NN from_IN
        1995_CD to_TO 1996_CD ._. This_DT is_VBZ likely_JJ due_NN to_TO a_DT combination_NN of_IN the_DT
        population_NN gain_NN and_CC the_DT aging_NN of_IN the_DT population_NN from_IN 1995_CD
        to_TO 1996_CD ._.
        In_IN conclusion_NN ,_, stroke_NN is_VBZ a_DT significant_JJ problem_NN in_IN the_DT
        United_NNP States_NNPS ._. The_DT importance_NN of_IN preventive_JJ measures_NNS for_IN a_DT
        disease_NN that_WDT has_VBZ identifiable_JJ and_CC modifiable_JJ risk_NN factors_NNS
        must_MD be_VB emphasized_VBN ._. The_DT reduction_NN of_IN morbidity_NN and_CC
        mortality_NN among_IN stroke_NN patients_NNS must_MD remain_VB a_DT public_JJ health_NN
        priority_NN ._.
      
      
        Competing_VBG interests_NNS
        None_NN declared_VBD
      
    
  
